Axogen Statistics
Total Valuation
Axogen has a market cap or net worth of $721.02 million. The enterprise value is $767.80 million.
Important Dates
The last earnings date was Tuesday, August 5, 2025, before market open.
Earnings Date | Aug 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Axogen has 46.01 million shares outstanding. The number of shares has increased by 4.78% in one year.
Current Share Class | 46.01M |
Shares Outstanding | 46.01M |
Shares Change (YoY) | +4.78% |
Shares Change (QoQ) | +6.14% |
Owned by Insiders (%) | 1.67% |
Owned by Institutions (%) | 87.76% |
Float | 45.24M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 671.24 |
PS Ratio | 3.43 |
Forward PS | 3.03 |
PB Ratio | 6.28 |
P/TBV Ratio | 6.85 |
P/FCF Ratio | 147.20 |
P/OCF Ratio | 101.22 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 88.77, with an EV/FCF ratio of 155.36.
EV / Earnings | n/a |
EV / Sales | 3.78 |
EV / EBITDA | 88.77 |
EV / EBIT | 448.48 |
EV / FCF | 155.36 |
Financial Position
The company has a current ratio of 4.14, with a Debt / Equity ratio of 0.63.
Current Ratio | 4.14 |
Quick Ratio | 2.32 |
Debt / Equity | 0.63 |
Debt / EBITDA | 5.57 |
Debt / FCF | 14.22 |
Interest Coverage | 0.22 |
Financial Efficiency
Return on equity (ROE) is -4.48% and return on invested capital (ROIC) is 0.61%.
Return on Equity (ROE) | -4.48% |
Return on Assets (ROA) | 0.54% |
Return on Invested Capital (ROIC) | 0.61% |
Return on Capital Employed (ROCE) | 0.95% |
Revenue Per Employee | $449,715 |
Profits Per Employee | -$10,316 |
Employee Count | 452 |
Asset Turnover | 1.03 |
Inventory Turnover | 1.61 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.06% in the last 52 weeks. The beta is 1.02, so Axogen's price volatility has been similar to the market average.
Beta (5Y) | 1.02 |
52-Week Price Change | +21.06% |
50-Day Moving Average | 13.45 |
200-Day Moving Average | 14.94 |
Relative Strength Index (RSI) | 60.12 |
Average Volume (20 Days) | 1,295,298 |
Short Selling Information
The latest short interest is 3.05 million, so 6.64% of the outstanding shares have been sold short.
Short Interest | 3.05M |
Short Previous Month | 4.10M |
Short % of Shares Out | 6.64% |
Short % of Float | 6.75% |
Short Ratio (days to cover) | 1.67 |
Income Statement
In the last 12 months, Axogen had revenue of $203.27 million and -$4.66 million in losses. Loss per share was -$0.10.
Revenue | 203.27M |
Gross Profit | 150.96M |
Operating Income | 1.71M |
Pretax Income | -16.54M |
Net Income | -4.66M |
EBITDA | 8.65M |
EBIT | 1.71M |
Loss Per Share | -$0.10 |
Full Income Statement Balance Sheet
The company has $29.92 million in cash and $70.27 million in debt, giving a net cash position of -$40.34 million or -$0.88 per share.
Cash & Cash Equivalents | 29.92M |
Total Debt | 70.27M |
Net Cash | -40.34M |
Net Cash Per Share | -$0.88 |
Equity (Book Value) | 112.28M |
Book Value Per Share | 2.45 |
Working Capital | 78.44M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $7.19 million and capital expenditures -$2.25 million, giving a free cash flow of $4.94 million.
Operating Cash Flow | 7.19M |
Capital Expenditures | -2.25M |
Free Cash Flow | 4.94M |
FCF Per Share | $0.11 |
Full Cash Flow Statement Margins
Gross margin is 74.27%, with operating and profit margins of 0.84% and -2.29%.
Gross Margin | 74.27% |
Operating Margin | 0.84% |
Pretax Margin | -2.29% |
Profit Margin | -2.29% |
EBITDA Margin | 4.25% |
EBIT Margin | 0.84% |
FCF Margin | 2.43% |
Dividends & Yields
Axogen does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.78% |
Shareholder Yield | -4.78% |
Earnings Yield | -0.64% |
FCF Yield | 0.68% |
Dividend Details Analyst Forecast
The average price target for Axogen is $26.00, which is 65.92% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $26.00 |
Price Target Difference | 65.92% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | 16.59% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Axogen has an Altman Z-Score of 3.47 and a Piotroski F-Score of 5.
Altman Z-Score | 3.47 |
Piotroski F-Score | 5 |